BioWorldNov. 20, 1992Vol. 4, No. 228


Cambridge Biotech Corp. (CBC) said Thursday it expects to beginconstruction of a $28 million, 95,000-square-footmanufacturing facility in conjunction with the WorcesterFoundation for Experimental Biology, a biomedical researchinstitute based in Shrewsbury, Mass.

The facility, to be located at Foundation Park in Shrewsbury,will become the headquarters and U.S. manufacturing facilityfor CBC's diagnostics division, which develops in vitrodiagnostics for infectious diseases.

According to Gary Long, the Worcester, Mass., company's(NASDAQ:CBCX) vice president of operations, the facility shouldbe in operation by summer 1995. Financial terms of the dealwere not disclosed.

(c) 1997 American Health Consultants. All rights reserved.